2-Bromo-4,5-methylenedioxyamphetamine

6-Bromo-MDA, also known as 6-bromo-3,4-methylenedioxyamphetamine or as 2-bromo-4,5-methylenedioxyamphetamine, is a lesser-known psychoactive drug of the phenethylamine, amphetamine, and MDxx families related to 3,4-methylenedioxyamphetamine. It is the 6-bromo derivative of MDA. In his 1991 book PiHKAL, Alexander Shulgin listed the dose as 350mg orally and the duration as unknown. 6-Bromo-MDA has been reported to produce amphetamine-like effects with no other details provided. However, Daniel Trachsel reported that 6-bromo-MDA was inactive at doses of up to 350mg. The drug was first described in the scientific literature by Silvia Sepaveda and colleagues by 1972.